Medline Inc. Class A Common Stock (MDLN) — Cash Flow Reinvestment Rate
Medline Inc. Class A Common Stock (MDLN) has a Cash Flow Reinvestment Rate of 0.16x as of June 2026, reinvesting $111.00 Million (capex $111.00 Million ) from operating cash flow of $715.00 Million. See Medline Inc. Class A Common Stock free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medline Inc. Class A Common Stock Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Medline Inc. Class A Common Stock across 4 annual periods. For the full cash flow conversion analysis, see Medline Inc. Class A Common Stock cash flow conversion.
Annual Cash Flow Reinvestment Rate for Medline Inc. Class A Common Stock (2022–2025)
Year-by-year capital reinvestment analysis for Medline Inc. Class A Common Stock. See Medline Inc. Class A Common Stock free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | $447.00 Million | $1.74 Billion | $447.00 Million | ▲ +24.6% |
| 2024 | 0.21x | $364.00 Million | $1.77 Billion | $364.00 Million | ▲ +21.7% |
| 2023 | 0.17x | $285.00 Million | $1.69 Billion | $285.00 Million | ▼ -87.5% |
| 2022 | 1.36x | $254.00 Million | $187.00 Million | $254.00 Million | — |